Breaking News Instant updates and real-time market news.

BSX

Boston Scientific

$35.50

-1.72 (-4.62%)

13:05
11/19/18
11/19
13:05
11/19/18
13:05

Boston Scientific price target raised to $42 from $40 at Stephens

Stephens analyst Chris Cooley raised his price target for Boston Scientific to 42 from $40 and reiterated an Overweight rating on the shares. The analyst believes the "requisite pieces" remain in place to enable Boston Scientific to potentially enhance the company's best-in-class organic revenue and non-GAAP earnings growth outlook as end markets continue to perform in-line, the portfolio continues to accrue share gains, planned new product launches and geographic expansion efforts stand to expand the addressable TAM, initiatives to increase margins by 50 to 100bps annually remain on track, and the company's enhanced financial position provides greater latitude for it to continue to invest in the core business while nimbly pursuing strategic opportunities as they may arise.

  • 27

    Nov

BSX Boston Scientific
$35.50

-1.72 (-4.62%)

10/24/18
PIPR
10/24/18
NO CHANGE
Target $40
PIPR
Overweight
Piper continues to recommend purchase of Boston Scientific after earnings
Piper Jaffray analyst Matt O'Brien says that while currency proved more of a drag than expected in Boston Scientific's Q3, the company's outlook remains "strong." There were a couple areas of modest weakness in the quarter, but the key growth drivers, namely Neuromod, MedSurg and Structural Heart, were "quite strong again," O'Brien tells investors in a post-earnings research note. The analyst believes Boston Scientific's market opportunities, along with new products, "will continue to buoy revenue results" in 2019 and 2020. He encourages investors to start or build positions in the name and keeps an Overweight rating on Boston Scientific with a $40 price target.
10/25/18
PIPR
10/25/18
NO CHANGE
Target $25
PIPR
Overweight
Nuvectra recent selloff brings 'excellent entry point,' says Piper Jaffray
Piper Jaffray analyst Matt O'Brien believes the recent Q3 results of neuromodulation incumbents, Boston Scientific (BSX) and Abbott (ABT), "reinforce the dynamic characteristics" of the spinal cord stimulation marketplace. Nuvectra's (NVTR) Algovita is likely one of the beneficiaries and could post upside in the quarter, O'Brien tells investors in a research note. The analyst says Nuvectra continues to be his top-microcap pick with a "reasonable valuation." Further, the recent softness in the shares "provides an excellent entry point for a name that is still in the early innings of gaining SCS share." He keeps an Overweight rating on Nuvectra with a $25 price target.
10/25/18
ADAM
10/25/18
NO CHANGE
Target $42
ADAM
Buy
Boston Scientific entering 2019 with best fundamentals ever, says Canaccord
Canaccord analyst Jason Mills noted Boston Scientific reported solid Q3 results and said there was nothing in the report to imply a loss of momentum. The analyst believes the company will enter 2019 with its best fundamentals in its history and is very well positioned to deliver organic revenue growth above its peers. Mills reiterated his Buy rating and raised his price target to $42 from $40 on Boston Scientific shares.
11/15/18
GUGG
11/15/18
NO CHANGE
Target $45
GUGG
Buy
Boston Scientific price target raised to $45 from $43 at Guggenheim
Guggenheim analyst Chris Pasquale raised his price target on Boston Scientific to $45 and kept his Buy rating, saying its recent acquisitions of 8 private companies for $1.5B has positioned the company for a "best-in-class" topline growth of over 10% in 2020. The analyst notes that the revenue impact of the acquisitions adds to his bullish thesis outlined in July when he added the stock to his Best Ideas list based on his expectation of Lotus coming to market and its non-TAVR pipeline being "underappreciated" by the Street.

TODAY'S FREE FLY STORIES

PI

Impinj

$20.47

0.65 (3.28%)

08:21
04/23/19
04/23
08:21
04/23/19
08:21
Initiation
Impinj initiated  »

Impinj initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

TACT

Transact Technologies

$9.23

0.21 (2.33%)

08:21
04/23/19
04/23
08:21
04/23/19
08:21
Conference/Events
Transact Technologies to hold a product demonstration of BOHA »

Product Showcase for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
04/23/19
04/23
08:20
04/23/19
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETTX

Entasis Therapeutics

$5.94

0.19 (3.30%)

08:20
04/23/19
04/23
08:20
04/23/19
08:20
Hot Stocks
Entasis Therapeutics appoints Eric Kimble as CCO »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
04/23/19
04/23
08:20
04/23/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
04/23/19
04/23
08:20
04/23/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$197.37

-0.195 (-0.10%)

08:20
04/23/19
04/23
08:20
04/23/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$78.00

0.17 (0.22%)

08:19
04/23/19
04/23
08:19
04/23/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$68.61

1.44 (2.14%)

08:19
04/23/19
04/23
08:19
04/23/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$118.83

-0.43 (-0.36%)

08:19
04/23/19
04/23
08:19
04/23/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.43

-0.37 (-0.64%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$57.23

-0.06 (-0.10%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMRD

Nemaura Medical

$0.98

-0.06 (-5.77%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Hot Stocks
Nemaura Medical completes two usability studies for SugarBEAT »

Nemaura Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$56.87

0.01 (0.02%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$85.97

0.07 (0.08%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$34.39

-0.01 (-0.03%)

08:18
04/23/19
04/23
08:18
04/23/19
08:18
Recommendations
Twitter analyst commentary at Baird »

Twitter Q2 guidance looks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

IWM

iShares Trust Russell 2000 Index Fund

$155.19

-0.44 (-0.28%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$265.04

-0.48 (-0.18%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$69.92

-0.02 (-0.03%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Hot Stocks
State Street says still targeting 4% productivity savings in FY19 »

Says "well…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 15

    May

  • 11

    Jun

SPY

SPDR S&P 500 ETF Trust

$290.30

0.31 (0.11%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$27.26

-0.08 (-0.29%)

08:17
04/23/19
04/23
08:17
04/23/19
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$117.63

-0.11 (-0.09%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$187.91

0.54 (0.29%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LH

LabCorp

$144.26

-0.94 (-0.65%)

08:16
04/23/19
04/23
08:16
04/23/19
08:16
Hot Stocks
LabCorp announces extension of distribution agreement with OmniSeq »

OmniSeq and LabCorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 09

    May

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.